Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has issued an update.
ASKA Pharmaceutical Holdings Co., Ltd. has been recognized under the FY2024 ‘Next Nadeshiko: Companies Supporting Dual-career and Co-parenting’ program, highlighting its efforts to support dual-career and co-parenting initiatives. The company has implemented flexible work systems, encourages male employees to take childcare leave, and provides career development opportunities, fostering an environment where employees can balance work and family life effectively.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the healthcare industry, focusing on the development of innovative products in prevention, testing/diagnosis, treatment, and prognosis. The company emphasizes the importance of human resources and aims to create a workplace where all employees can actively contribute.
YTD Price Performance: 9.91%
Average Trading Volume: 53,929
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen61.4B
For an in-depth examination of 4886 stock, go to TipRanks’ Stock Analysis page.